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Background 
 
Administration of inhaled oxygen to patients with acute myocardial infarction 
(MI) has been recommended in national and international guidelines 
(Kallstrom 2002, American Heart Association 2004, American Heart 
Association 2005, International Liaison Committee on Resuscitation 2005, 
Anderson et al 2007, Antman et al 2004, , Van de Werf 2007) and has been a 
mainstay of pre-hospital management for decades. Compliance with guideline 
recommendations is high: in a 2007 survey of over 500 UK emergency 
departments, cardiology and ambulance staff  98.3% reported always or 
usually using oxygen in patients suffering a heart attack. (Burls et al 2010)  
Similarly 86% of Spanish cardiologists responding to a parallel survey 
(N=169) reported routinely using oxygen in uncomplicated MI. (Cabello et al 
2010) 
 
Emerging UK guidelines are beginning to diverge from the previous 
consensus that oxygen should routinely be administered in AMI.  For 
example, the Scottish Intercollegiate Guidelines Network (SIGN, 2008)  
restricts recommendations on oxygen in acute coronary syndrome (ACS)  to 
use with hypoxic patients and those with pulmonary oedema or continuing 
myocardial ischaemia.  They make clear that this is based on expert opinion 
alone. The recent British Thoracic Society (2008) guidelines on emergency 
oxygen use in adult patients, recommend that AMI patients should receive 
oxygen only if hypoxaemic, a recommendation again based on expert 
consensus rather than hard evidence. The Joint Royal Colleges Ambulance 
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Liaison Committee (JRCALC, 2010) and more recently the National Institute 
for Health and Clinical Excellence (NICE, 2010)  have used a similar 
formulation in their respective guidelines.  
 
What is the evidence that oxygen is harmful or beneficial in AMI? 
 
A number of systematic reviews in recent years have cast doubt on the safety 
and efficacy of oxygen in AMI, citing various possible mechanisms by which 
harm may be induced. However, the evidence either way is weak. 
 
Nicholson (2004) from the UK reviewed human studies, some non-
randomised, concluding that oxygen administration did not reduce acute 
myocardial ischaemia, with some evidence suggesting that it may actually 
increase ischaemia. 
 
Wijesenghe et al (2008) from New Zealand reviewed the effect of oxygen on 
infarct size and concluded: “There is little evidence by which to determine the 
efficacy and safety of high flow oxygen therapy in MI. The evidence that does 
exist suggests that the routine use of high flow oxygen in uncomplicated MI 
may result in a greater infarct size and possibly increase the risk of mortality."  
 
From the same group, Farquhar et al (2009) reported a systematic review of 
studies measuring coronary blood flow, concluding that hyperoxia from high-
concentration oxygen therapy caused marked reduction in coronary blood 
flow and myocardial oxygen consumption.  
 4 
 
A recent Cochrane systematic review undertaken by the present authors 
brought the evidence up to date by including a trial from Russia, in the primary 
PCI era, that had not been identified by authors of previous evidence 
syntheses. We found only three trials out of more than 2500 studies identified 
through a comprehensive search of the literature.  These three trials (one 
each from the pre-thrombolysis, thrombolysis and primary PCI eras) together 
recruited a total of 387 patients, of whom 14 died. The combined relative risk 
(RR) of death in those receiving oxygen compared with air was 2.88 (95%CI 
0.88 to 9.39) in an intention-to-treat analysis and 3.03 (95%CI 0.93 to 9.83) in 
patients with confirmed AMI.   
 
While suggestive of harm, it is important to recognise that the small number of 
deaths could be a chance occurrence. No difference was found in pain 
measured by analgesic use: the pooled RR for use of analgesics was 0.97 
(95%CI 0.78 to 1.20). (Cabello et al 2010)  Publication of our review 
prompted the British Heart Foundation (2010) to revise their position on the 
role of oxygen in AMI and to call for more research in this area. A BMJ 
editorial commissioned to coincide with publication of our review 
recommended that oxygen continue to be routinely used based on 
pathophysiological reasoning (Atar 2010) although this has led to 
considerable correspondence, not least from the authors of the BTS guideline, 
who have called for the editorial to be retracted. Clearly there is ongoing 
uncertainty about the role of oxygen in AMI. 
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Underlying mechanisms that may be harmful 
 
It is biologically plausible that oxygen is doing harm.  Potentially harmful 
mechanisms include the paradoxical effect of reducing coronary blood flow and 
increasing coronary vascular resistance (McNulty et al 2005, McNulty et al 
2007); reduced stroke volume and cardiac output  (Milone et al 1990); other 
adverse haemodynamic consequences, such as increased vascular resistance 
from hyperoxia; and reperfusion injury from increased oxygen free radicals. 
(Rousseau et al 2005, Farquhar et al 2009) 
 
Ongoing and future trials 
 
We searched ClinicalTrials.gov and the World Health Organisation 
International Clinical Trials Registry Platform for ongoing trials of oxygen in 
AMI and identified two studies, from Australia and New Zealand, neither of 
which (one hospital based, the other pre-hospital, recruiting 200 patients 
each) is powered for mortality. We have calculated that around 10 thousand 
patients would need to be randomised to receive oxygen, and another 10 
thousand to air, to address the question of whether oxygen improves or 
increases mortality. We are therefore working with colleagues from 
ambulance services, cardiology, emergency medicine and public health to 
plan such a trial. 
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What should the clinician do in the face of ongoing uncertainty about 
the role of oxygen in AMI? 
 
In 2010 we still do not know whether routine oxygen administration is 
beneficial, harmful, or irrelevant in AMI.  Nor do we have robust evidence that 
oxygen is beneficial in ‘complicated’ patients such as those with shock or 
arrhythmia. More important than moving from one set of guideline 
recommendations based on expert opinion to a different set of guideline 
recommendations based on expert opinion, we need to generate good 
evidence, from adequately powered randomised controlled trials (RCTs) to 
guide decisions on which patients across the spectrum of ACS - if any - 
should receive oxygen, at what dose, and for how long.  A high quality RCT 
should urgently be conducted to resolve this uncertainty before more people 
are either harmed or deprived of benefit.  
 
In the absence of high quality evidence to guide practice, we think it is 
reasonable for clinicians to follow existing national and international guideline 
recommendations, which are based on expert consensus, until they are either 
confirmed or refuted by high quality research. An important role for ambulance 
clinicians in helping to resolve the ongoing uncertainties about the role of 
oxygen in AMI/ACS will be to participate, in the context of the regulations 
governing clinical trials in emergency situations (Shakur et al 2007) in ethically 
approved RCTs.   
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